Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. OpGen, Inc.
  6. News
  7. All News
    OPGN   US68373L3078

OPGEN, INC.

(OPGN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
All news about OPGEN, INC.
06/09OPGEN  : Announces Partial Adjournment of Annual Meeting for Proposal 2 with All..
PU
06/09OPGEN INC  : Submission of Matters to a Vote of Security Holders, Other Events, ..
AQ
06/09OpGen Announces Partial Adjournment of Annual Meeting for Proposal 2 with All..
GL
06/09OpGen Group Company Ares Genetics Presents at AWS and Twist Bioscience Webina..
GL
06/07OpGen Submits Updated 510(k) Summary to FDA and Successfully Completes Move t..
GL
06/01OPGEN  : Corporate Presentation (PDF)
PU
05/14OPGEN  : Note 2 - Going Concern and Management's Plans
AQ
05/14OPGEN  : Reports First Quarter 2021 Financial Results and Provides Business Upda..
PU
05/13OPGEN INC  : Results of Operations and Financial Condition, Financial Statements..
AQ
05/13OPGEN  : Earnings Flash (OPGN) OPGEN Posts Q1 Loss $-0.50
MT
05/13OPGEN  : Earnings Flash (OPGN) OPGEN Reports Q1 Revenue $830,000, vs. Street Est..
MT
05/13OpGen Reports First Quarter 2021 Financial Results and Provides Business Upda..
GL
05/02OPGEN  : Corporate Presentation (PDF)
PU
04/29OPGEN TO PROVIDE BUSINESS UPDATE AND : 30 a.m. Eastern Time
GL
04/19OPGEN  : Corporate Presentation (PDF)
PU
04/19OpGen Extends and Expands Partnership with New York State Department of Healt..
GL
04/12OpGen Announces Results from Successful Webinar on Bacterial Pneumonia Co-inf..
GL
03/30OPGEN  : Corporate Presentation (PDF)
PU
03/29OPGEN  : Management's Discussion and Analysis of Financial Condition and Results..
AQ
03/25OPGEN INC  : Results of Operations and Financial Condition, Financial Statements..
AQ
03/25OPGEN  : Q4 Loss Narrows as Revenue Climbs YOY
MT
03/25OPGEN  : Earnings Flash (OPGN) OPGEN Posts Q4 Revenue $1.4M, vs. Street Est of $..
MT
03/25OPGEN  : Reports Fourth Quarter and Full Year 2020 Financial Results and Provide..
AQ
03/11OpGen to Provide Business Update and Financial Results for the Fourth Quarter..
GL
03/09OPGEN INC  : Entry into a Material Definitive Agreement, Unregistered Sale of Eq..
AQ
03/08OPGEN INC  : Change in Directors or Principal Officers, Other Events (form 8-K)
AQ
03/08OPGEN  : Corporate Presentation (PDF)
PU
03/08OpGen Announces Publication of Final Study Results of Unyvero HPN Panel for D..
GL
03/02OPGEN  : Alliance Global Partners Adjusts Price Target on OpGen to $7 From $5.65..
MT
03/02OPGEN  : Corporate Presentation (PDF)
PU
03/01OpGen Wins Chinese NMPA Approval for the Curetis Unyvero System
GL
02/16OPGEN  : Corporate Presentation (PDF)
PU
02/16OpGen Subsidiary Ares Genetics Announces Publication of Study Introducing Bes..
GL
02/10OPGEN INC  : Entry into a Material Definitive Agreement, Unregistered Sale of Eq..
AQ
02/09OpGen, Inc. Announces $25 Million Registered Direct Offering Priced At-the-Ma..
GL
02/01OPGEN  : Corporate Presentation (PDF)
PU
01/13OPGEN INC  : Results of Operations and Financial Condition, Financial Statements..
AQ
01/13OPGEN  : Corporate Presentation (PDF)
PU
01/13OpGen Announces Preliminary Unaudited Revenue for Fiscal 2020 and Provides Bu..
GL
01/05OPGEN  : Corporate Presentation (PDF)
PU
01/05OpGen Subsidiary Curetis and Annar Enter into Unyvero Distribution Partnershi..
GL
2020RESULTS FROM 1,400 PATIENT SAMPLE MU : Unyvero LRT BAL Panel Provides Accurate D..
AQ
2020OpGen Announces Planned Leadership Transition at Next Generation Sequencing a..
GL
2020OPGEN  : Corporate Presentation (PDF)
PU
2020OpGen Group Company Ares Genetics Advances ares-genetics.cloud Platform, Pres..
GL
2020OPGEN INC  : Entry into a Material Definitive Agreement, Unregistered Sale of Eq..
AQ
2020OPGEN  : Announces $10 Million Private Placement Priced at the Market
AQ
2020OpGen, Inc. Announces $10 Million Private Placement Priced at the Market
GL
2020OPGEN  : Note 2 - Liquidity and management's plans
AQ
2020OPGEN  : Corporate Presentation (PDF)
PU
2020OPGEN INC  : Entry into a Material Definitive Agreement, Other Events, Financial..
AQ
2020OPGEN  : Alliance Global Partners Adjusts OpGen PT to $5.65 From $5, Maintains B..
MT
2020OPGEN  : Ares Genetics Commercially Launches NGS-based Antibiotic Resistance Tes..
AQ
2020OpGen Group Company Ares Genetics Commercially Launches NGS-based Antibiotic ..
GL
2020OPGEN INC  : Results of Operations and Financial Condition, Financial Statements..
AQ
2020OPGEN  : Earnings Flash (OPGN) OPGEN Posts Q3 Revenue $1.1M, vs. Street Est of $..
MT
2020OPGEN  : Reports Third Quarter 2020 Financial Results and Provides Business Upda..
AQ
2020OpGen Reports Third Quarter 2020 Financial Results and Provides Business Upda..
GL
2020OPGEN INC  : Change in Directors or Principal Officers, Financial Statements and..
AQ
2020OPGEN  : to Provide Business Update and Financial Results for the Third Quarter ..
AQ
2020OpGen to Provide Business Update and Financial Results for the Third Quarter ..
GL
2020OPGEN  : Announces Award of German Government Grant Funding to its Subsidiary Cu..
AQ
2020OpGen Announces Award of German Government Grant Funding to its Subsidiary Cu..
GL
2020OPGEN  : Corporate Presentation (PDF)
PU
2020OPGEN INC  : Results of Operations and Financial Condition (form 8-K)
AQ
2020OPGEN  : Provides Business and Pipeline Update and Announces Preliminary Unaudit..
AQ
2020OpGen Provides Business and Pipeline Update and Announces Preliminary Unaudit..
GL
2020OPGEN  : Issues Formal Response to FDA's Requests for Additional Information and..
AQ
2020OpGen Issues Formal Response to FDA's Requests for Additional Information and..
GL
2020OPGEN  : Corporate Presentation (PDF)
PU
2020OPGEN  : Ares Genetics Wins Austrian Digitization Award for ares-genetics.cloud
AQ
2020OpGen Group Company Ares Genetics Wins Austrian Digitization Award for ares-g..
GL
2020OPGEN INC  : Change in Directors or Principal Officers, Submission of Matters to..
AQ
2020OPGEN  : Announces Award of German Government Grant Funding to its Subsidiary Cu..
AQ
2020OpGen Announces Award of German Government Grant Funding to its Subsidiary Cu..
GL
1  2  3Next
Upcoming event on OPGEN, INC.